Dr Krishnamurthy Bhat


Department of Pharmaceutical Quality Assurance


    Dr. Krishnamurthy Bhat is Head of the Pharmaceutical Quality Assurance department. He is actively involved in the academic and research activities of the department. He has many funded projects ongoing under his supervision.

    Dr. Bhat supervises Mpharm and Ph.D. students, and teaches undergraduates and postgraduates.


Subject Semester / Year
Pharmaceutical Analysis-II Final year Bharm
Pharmaceutical Analysis Lab Final year Bharm
Modern Pharmaceutical Analytical Techniques MPharm- First semester
Documentation and Regulatory Writing MPharm- First semester
Regulatory Affairs practicals-I MPharm- First semester


Degree Specialisation Institute Year of passing
BPharm JSS College of Pharmacy, Mysore 1991
MPharm Quality Assurance LM College of Pharmacy 1995
Ph.D. Pharmaceutical Sciences Gujarat University 2004


Institution / Organisation Designation Role Tenure
LM College of Pharmacy: Ahmedabad, Gujarat, India Senior Research Scholar Researcher 1.5 years
KB Institute of Pharmaceutical Education and Research: Gandhinagar, Gujarat, India Lecturer Teaching 06 years
KB Institute of Pharmaceutical Education and Research: Gandhinagar, Gujarat, India Assistant Professor Teaching 05 Months
Manipal College of Pharmaceutical Sciences: Manipal, Karnataka, India Lecturer Teaching and Research 01 year
Manipal College of Pharmaceutical Sciences: Manipal, Karnataka, India Associate Professor Teaching and Research 03 Years


Area of Expertise

Pharmaceutical Analysis, Pharmaceutical Materials Science, Pharmacokinetics

Professional Affiliations & Contributions

Dr. Krishnamurthy Bhat has a primary research interest in analytical method development and validation for new drugs and new methods for existing drugs. This is evidenced by his publication list of various analytical techniques and instrument combinations. He is also an avid follower of drug regulations of important countries and does some research on the evolution of comparison of these regulations. Crystal engineering and formulation modifications as tools for improving bioavailability of drugs are another area where Dr. Bhat is actively researching.

His expertise in these areas can be judged by his publications in journals like Arzneimittel-Forschung, Journal of Pharmaceutical and Biomedical Analysis, European Journal of Pharmaceutical Sciences, European Journal of Pharmaceutics and Biopharmaceutics etc. He is also an reviewer for few journals, expert committee members for various universities across the country.

The author credentials and citation graphs can be accessed by following platforms,

Scopus author ID: 25937181100

ORCID ID: orcid.org/0000-0002-8604-472X

Google scholar link:


Peer review record can be verified at:

PUBLON ID: publons.com/author/741664/Krishnamurthy-bhat#profile

Work Experience

Organisation Role Tenure
Bangalore Pharmaceutical and Research Labs Pvt Ltd: Bangalore, Karnataka, India Manufacturing Executive 04 Years
Bangalore Pharmaceutical and Research Labs Pvt Ltd: Bangalore, Karnataka, India Quality Assurance Executive 01 year

LC determination and pharmacokinetics of meloxicam.

B Dasandi H Saroj Krishnamurthy Bhat

Journal of pharmaceutical and biomedical analysis, Vol. 28 (2002)

Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method

A Karthik G Subramanian CM Rao Krishnamurthy Bhat P Musmade M Surulivel Rajan

Pakistan journal of pharmaceutical sciences, Vol. 21 (2008)

Enhanced oral absorption of saquinavir with methyl-beta-cyclodextrin—preparation and in vitro and in vivo evaluation

SM Pathak P Musmade A Karthik Krishnamurthy Bhat

European Journal of Pharmaceutical Sciences, Vol. 41 (2010)

Estimation of Stavudine, Lamivudine and Nevirapine by Chemometric UV Spectroscopic Method

A Gupta ST Bhagawati Muddukrishna Badamane Sathyanarayana Krishnamurthy Bhat

Ind J Pharm Edu Res, Vol. 46

Preparation and characterization of co-amorphous Ritonavir–Indomethacin systems by solvent evaporation technique: Improved dissolution behavior and physical stability without evidence of intermolecular interactions

OP Ranjan SS Hussen Muddukrishna Badamane Sathyanarayana PB Musmade Krishnamurthy Bhat

European Journal of Pharmaceutical Sciences, Vol. 62, (2013)

Simultaneous estimation of emicitrabine, efavirenz, tenofovir disproxil fumerate by chemometry and reverse phase high performance liquid chromatography.

G. ramya Kumari Deepika N. C. Krishnamurthy Bhat

53(06) June 2016, 62 – 69.

Bioavailability enhancement of Rizatriptan Benzoate by oral disintegrating Strip: In vitro and in vivo evaluation.

S. T. Bhawati Ankita D. Chonkar Krishnamurthy Bhat

Current Drug Delivery 2016 13(3), 462 - 70.

Development and validation of reversed­phase high­performance liquid chromatography method for estimation of rizatriptan benzoate in oral strip formulations.

S. T. Bhagawati Kiran Avadani Muddukrishna Badamane Sathyanarayana Krishnamurthy Bhat

J. of Basic and Clinical Pharmacy 6(1) December – February 2015, 7 – 11.

Trademark and their related issues

Ankur Singh

MPharm Part-II (2015)

Clinical research and it’s regulatory impact in India

Smita Sagarika B

MPharm Part-II (2015)

Regulatory Scenrio of Prefilled syringes in developed markets

MD Sadiq Pasha

MPharm Part-II (2015)

Significance of regulatory information management in pharmaceutical industry

Vinay Thallapally

MPharm Part-II (2015)

Development and Validation of an analytical method for related substances in N-Acetyl-L-Cystine Effervescent tablets by RP-HPLC

Elizabeth Marry Mathew

MPharm Part-II (2015)

Qualification and facility validation of sterile dry powder for injections.

Deepika N. C.

MPharm part-II (2016)

Bioanalytical method development and validation for the quantification of sofosbuvir in human plasma by RP – HPLC.

Rahul U. Rathod

MPharm part-II (2016)

Analytical method development and validation for the determination of moxifloxacon in marketed formulations by using HPLC – ECD.

G. Phani Sekhar Reddy

MPharm part-II (2016)